Cite

HARVARD Citation

    Obazee, O. et al. (2019). Germline BRCA2 K3326X and CHEK2 I157T mutations increase risk for sporadic pancreatic ductal adenocarcinoma. International journal of cancer. 145 (3), pp. 686-693. [Online]. 
  
Back to record